In vivo transfer of a functional copy of CFTR has been envisioned as a CF airway treatment since 1989 when the CFTR gene was identified as the cause of this multisystemic disease (Tsui et al., 1985; Wainwright et al., 1985). Here, CFTR is linked to cystic fibrosis.